Home › Obesity › Arizona › Chandler
Obesity clinical trials in Chandler, AZ
5 studies for Obesity are looking for participants at sites in and around Chandler (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
RecruitingPhase 2
- The Institute for Liver Health II dba Arizona Clinical Trials - Mesa, Chandler
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
RecruitingPhase 3Healthy volunteers welcome
- ACCOMPLISH-2 Research Site, Chandler
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
RecruitingPhase 2
- The Institute for Liver Health II dba Arizona Clinical Trials - Mesa, Chandler
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
RecruitingPhase 3
- Arizona Clinical Trials, Chandler
A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)
RecruitingPhase 1/2
- Arizona Liver Health, Chandler
About Obesity
Read about the causes of obesity and find out what you can do to decrease your risk of its associated health issues.
More about Obesity on MedlinePlus
Obesity trials in other cities
- Houston, TX43 studies
- Chicago, IL41 studies
- New York City, NY40 studies
- San Antonio, TX40 studies
- Washington, DC33 studies
- Orlando, FL31 studies
- Dallas, TX30 studies
- Boston, MA28 studies
- Las Vegas, NV27 studies
- Miami, FL27 studies
- Baltimore, MD25 studies
- Jacksonville, FL25 studies
Other studies in Chandler
- Steatotic Liver Disease10 studies
- Non-Small Cell Lung Cancer5 studies
- Breast Cancer5 studies
- Colorectal Cancer5 studies
- Digestive Diseases5 studies
- Metastatic Cancer4 studies
- Type 2 Diabetes4 studies
- Overweight4 studies
- Liver Diseases4 studies
- Cirrhosis3 studies
- Alzheimer's Disease3 studies
- Cardiovascular Disease3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.